Literature DB >> 19931190

Role of the innate immune system in the pathogenesis of multiple sclerosis.

Roopali Gandhi1, Alice Laroni, Howard L Weiner.   

Abstract

Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease with heterogeneous clinical presentations and course. MS is considered to be a T cell mediated disease but in recent years contribution of innate immune cells in mediating MS pathogenesis is being appreciated. In this review, we have discussed the role of various innate immune cells in mediating MS. In particular, we have provided an overview of potential anti-inflammatory or pro-inflammatory function of DCs, microglial Cells, NK cells, NK-T cells and gamma delta T cells along with their interaction among themselves and with myelin. Given the understanding of the role of the innate immune cells in MS, it is possible that immunotherapeutic intervention targeting these cells may provide a better and effective treatment. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19931190      PMCID: PMC2854189          DOI: 10.1016/j.jneuroim.2009.10.015

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  146 in total

Review 1.  NK cells and Treg cells: a fascinating dance cheek to cheek.

Authors:  Jacques Zimmer; Emmanuel Andrès; François Hentges
Journal:  Eur J Immunol       Date:  2008-11       Impact factor: 5.532

2.  Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cells.

Authors:  D Kempuraj; M Tagen; B P Iliopoulou; A Clemons; M Vasiadi; W Boucher; M House; A Wolfberg; T C Theoharides
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

3.  Human mast cells stimulate activated T cells: implications for multiple sclerosis.

Authors:  Theoharis C Theoharides; Duraisamy Kempuraj; Taxiarchis Kourelis; Akrivi Manola
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

4.  Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation.

Authors:  Laura Piccio; Cecilia Buonsanti; Marina Cella; Ilaria Tassi; Robert E Schmidt; Chiara Fenoglio; John Rinker; Robert T Naismith; Paola Panina-Bordignon; Nadia Passini; Daniela Galimberti; Elio Scarpini; Marco Colonna; Anne H Cross
Journal:  Brain       Date:  2008-09-12       Impact factor: 13.501

5.  Mitomycin C-treated dendritic cells inactivate autoreactive T cells: toward the development of a tolerogenic vaccine in autoimmune diseases.

Authors:  Peter Terness; Thilo Oelert; Sandra Ehser; Jing Jing Chuang; Imad Lahdou; Christian Kleist; Florian Velten; Günter J Hämmerling; Bernd Arnold; Gerhard Opelz
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-18       Impact factor: 11.205

6.  Expression of TWEAK and its receptor Fn14 in the multiple sclerosis brain: implications for inflammatory tissue injury.

Authors:  Barbara Serafini; Roberta Magliozzi; Barbara Rosicarelli; Richard Reynolds; Timothy S Zheng; Francesca Aloisi
Journal:  J Neuropathol Exp Neurol       Date:  2008-12       Impact factor: 3.685

7.  Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis.

Authors:  Gopal Murugaiyan; Akanksha Mittal; Howard L Weiner
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

8.  NKT cells prevent chronic joint inflammation after infection with Borrelia burgdorferi.

Authors:  Emmanuel Tupin; Mohammed Rafii-El-Idrissi Benhnia; Yuki Kinjo; Rebeca Patsey; Christopher J Lena; Matthew C Haller; Melissa J Caimano; Masakazu Imamura; Chi-Huey Wong; Shane Crotty; Justin D Radolf; Timothy J Sellati; Mitchell Kronenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-05       Impact factor: 11.205

Review 9.  Microglial clearance function in health and disease.

Authors:  I Napoli; H Neumann
Journal:  Neuroscience       Date:  2008-07-01       Impact factor: 3.590

Review 10.  The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?

Authors:  Howard L Weiner
Journal:  Ann Neurol       Date:  2009-03       Impact factor: 10.422

View more
  106 in total

1.  Flow cytometric assay detecting cytotoxicity against human endogenous retrovirus antigens expressed on cultured multiple sclerosis cells.

Authors:  A Møller-Larsen; T Brudek; T Petersen; E L Petersen; M Aagaard; D T Hansen; T Christensen
Journal:  Clin Exp Immunol       Date:  2013-09       Impact factor: 4.330

Review 2.  Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.

Authors:  Janos Paloczi; Zoltan V Varga; George Hasko; Pal Pacher
Journal:  Antioxid Redox Signal       Date:  2017-07-18       Impact factor: 8.401

3.  Natural killer cell subsets in cerebrospinal fluid of patients with multiple sclerosis.

Authors:  E Rodríguez-Martín; C Picón; L Costa-Frossard; R Alenda; S Sainz de la Maza; E Roldán; M Espiño; L M Villar; J C Álvarez-Cermeño
Journal:  Clin Exp Immunol       Date:  2015-05       Impact factor: 4.330

Review 4.  Multiple sclerosis and the role of immune cells.

Authors:  Rune A Høglund; Azzam A Maghazachi
Journal:  World J Exp Med       Date:  2014-08-20

5.  Adenosine Promotes the Recovery of Mice from the Cuprizone-Induced Behavioral and Morphological Changes while Effecting on Microglia and Inflammatory Cytokines in the Brain.

Authors:  Jinling Zhang; Liu Yang; Zeman Fang; Jiming Kong; Qingjun Huang; Haiyun Xu
Journal:  J Neuroimmune Pharmacol       Date:  2018-08-01       Impact factor: 4.147

Review 6.  Toll-like receptors are key players in neurodegeneration.

Authors:  Daniela S Arroyo; Javier A Soria; Emilia A Gaviglio; Maria C Rodriguez-Galan; Pablo Iribarren
Journal:  Int Immunopharmacol       Date:  2011-05-25       Impact factor: 4.932

Review 7.  Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis.

Authors:  Regina Berkovich; Mark A Agius
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

8.  KIR2DL4-HLAG interaction at human NK cell-oligodendrocyte interfaces regulates IFN-γ-mediated effects.

Authors:  P P Banerjee; L Pang; S S Soldan; S M Miah; A Eisenberg; S Maru; A Waldman; E A Smith; Y Rosenberg-Hasson; D Hirschberg; A Smith; D V Ablashi; K S Campbell; J S Orange
Journal:  Mol Immunol       Date:  2018-11-24       Impact factor: 4.407

9.  Cell Type-Specific Intralocus Interactions Reveal Oligodendrocyte Mechanisms in MS.

Authors:  Daniel C Factor; Anna M Barbeau; Kevin C Allan; Lucille R Hu; Mayur Madhavan; An T Hoang; Kathryn E A Hazel; Parker A Hall; Sagar Nisraiyya; Fadi J Najm; Tyler E Miller; Zachary S Nevin; Robert T Karl; Bruna R Lima; Yanwei Song; Alexandra G Sibert; Gursimran K Dhillon; Christina Volsko; Cynthia F Bartels; Drew J Adams; Ranjan Dutta; Michael D Gallagher; William Phu; Alexey Kozlenkov; Stella Dracheva; Peter C Scacheri; Paul J Tesar; Olivia Corradin
Journal:  Cell       Date:  2020-04-03       Impact factor: 41.582

Review 10.  Is the CCR5 Δ 32 mutation associated with immune system-related diseases?

Authors:  Khodayar Ghorban; Maryam Dadmanesh; Gholamhossein Hassanshahi; Mohammad Momeni; Mohammad Zare-Bidaki; Mohammad Kazemi Arababadi; Derek Kennedy
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.